FENC Fennec Pharmaceuticals Inc.
$10.96▼ -3.01%
Healthcare
Other
After hours
$10.96▲ +0.00%
Sep 11, 7:30 PM ET
Volume 249.9K
Avg Volume (10D) 315.2K
Key Metrics & Fundamentals
Market Cap
$384.34M
P/E Ratio
–
Div Yield
–%
52W Range
5.65 - 13.25
% vs 50 MA
-1.07%
% vs 200 MA
25.86%
RSI-14
42.8
MACD Histogram
-0.1600
Beta (1Y vs SPY)
1.35
Free Cash Flow
$50,000
Gross Rev
$17.87M
Gross Profit
$17.15M
EBITDA
$2.05M
COGS
$721,000
Operating Exp
$15.42M
Operating Income
$1.74M
EBIT
$1.74M
Pretax Income
$2.02M
Net Income
$1.97M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News

Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views
Simply Wall St. · Aug 14, 2026 9:16 AM

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?
Zacks · Aug 12, 2026 1:55 PM
Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ...
GuruFocus.com · Aug 11, 2026 9:02 PM
Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat
MT Newswires · Aug 11, 2026 4:44 PM

Adherex Technologies Q2 Earnings Call Highlights
MarketBeat · Aug 11, 2026 3:05 PM
Fennec Pharmaceuticals surges 8% as Q2 earnings and revenue beat estimates
InvestorsHub · Aug 11, 2026 2:20 PM
Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates
Zacks · Aug 11, 2026 12:20 PM
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 11, 2026 11:01 AM
Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 10, 2026 9:10 PM
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
GlobeNewswire · Aug 5, 2026 11:01 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See FENC's money flow as a full page
Social Sentiment
No Reddit posts found for FENC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.